SARS-CoV-2 variants: A continuing threat to global health

• 作者: Balamurugan Shanmugaraj Narach Khorattanakulchai Waranyoo Phoolcharoen
• 来源期刊: 亚太热带医药杂志（英文版）
• 年，卷（期）: 2022,（1）
• 所属期刊栏目: Perspectives
• 页码范围: 1-3
• 页数: 3页
• 语种: 英文
• DOI: 10.4103/1995-7645.334716

摘要

Coronavirus disease 2019 (COVID-19) is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 pandemic has an unprecedented impact on economy, trade and human lifestyle globally. Since the emergence of of SARS-CoV-2, more than 266 million infections and 5?260888 deaths were reported globally over the last two years[1]. The scientific achievements particularly in last two years yielded effective vaccines against COVID-19. A variety of platform technologies including protein subunit, viral vector, RNA, inactivated and DNA are being employed to develop effective vaccines.